Connect your AI

CG Oncology CGON Payments to notes receivables

Payments to notes receivables at other companies

Acadia Realty TrustAKR

$76K+61.7%

Highwoods PropertiesHIW

$0-100%

Sabra HealthcareSBRA

$0-100%

Euronet WorldwideEEFT

$25M—

COPT Defense PropertiesCDP

$0-100%

Schneider NationalSNDR

$0-100%

Other financials

Income statement

Revenue$1.1M+1,983%

Operating income-$66.4M-57.3%

Net income-$60.2M-74.7%

EPS (diluted)-$0.71-57.8%

Balance sheet

Cash & equivalents$33.7M-18.7%

Total debt$7.6M+631%

Total equity$1.1B+54.9%

Total assets$1.1B+55.9%

Cash flow

Operating cash flow-$56.9M-94.5%

CapEx$304.0K+1,800%

Free cash flow-$57.2M-95.4%

Valuation

Market cap$5.8B+206%

Profitability

Operating margin-4,239%-1,872pp

Net margin-3,682.6%-1,601pp

FCF margin-3,163.8%-1,351pp

Returns & leverage

Return on equity-20.8%+7.1pp

Debt / equity0×0.0×

Current ratio31.3×+0.3×

Where this comes from

Reported directly by CG Oncology in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireNotesReceivable.

The official record: CG Oncology’s 10-Q, filed August 8, 2025, on SEC EDGAR. View the filing →

Ask your AI about CG Oncology's payments to notes receivables.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is CG Oncology's payments to notes receivables?: CG Oncology (CGON) reported payments to notes receivables of $1M in Q2 2025.